PHIO PHARMACEUTICALS CORP. Prepaid Expense, Current
PHIO PHARMACEUTICALS CORP. (PHIO) had Prepaid Expense, Current of $843.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2022-11-10
- 2022-09-30: Prepaid Expense, Current $843.00K.
- 2022-06-30: Prepaid Expense, Current $1.62M.
- 2022-03-31: Prepaid Expense, Current $1.16M.
- 2021-12-31: Prepaid Expense, Current $620.00K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2022-09-30 | $843.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.62M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.16M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $620.00K 10-Q · filed 2022-11-10 |
| 2017-09-30 | $271.00K 10-Q/A · filed 2018-03-26 |
| 2017-06-30 | $337.00K 10-Q/A · filed 2018-03-26 |
| 2017-03-31 | $125.00K 10-Q/A · filed 2018-03-26 |
| 2016-12-31 | $150.00K 10-Q/A · filed 2018-03-26 |
| 2016-09-30 | $321.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $477.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $265.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $311.00K 10-K · filed 2017-03-30 |
| 2014-12-31 | $442.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |